Screener
Agios Pharmaceuticals AGIO Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's asset turnover?
- Agios Pharmaceuticals (AGIO) reported asset turnover of 0.1× in Q2 2026.
- How has Agios Pharmaceuticals's asset turnover changed year-over-year?
- Agios Pharmaceuticals's asset turnover increased by 109.3% year-over-year, from 0× to 0.1×.
- What is the long-term trend for Agios Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's asset turnover has grown at a -31.0% compound annual growth rate (CAGR), from 0.2× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Agios Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude